BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3036349)

  • 1. Vinca alkaloids in the treatment of non-small cell lung cancer.
    Sørensen JB; Osterlind K; Hansen HH
    Cancer Treat Rev; 1987 Mar; 14(1):29-51. PubMed ID: 3036349
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
    Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
    Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
    Kanazawa J; Morimoto M; Ohmori K
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery systems and combination therapy by using vinca alkaloids.
    Lee CT; Huang YW; Yang CH; Huang KS
    Curr Top Med Chem; 2015; 15(15):1491-500. PubMed ID: 25877096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy.
    Rivera MP; Kris MG; Gralla RJ; White DA
    Am J Clin Oncol; 1995 Jun; 18(3):245-50. PubMed ID: 7747713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.
    Zhang Y; Yang SH; Guo XL
    Biomed Pharmacother; 2017 Dec; 96():659-666. PubMed ID: 29035832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis.
    Pignon JP; Stewart LA
    Cancer; 1996 Jun; 77(11):2413-4. PubMed ID: 8635115
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
    Kubota K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of terminal pain in cancer patients by means of iontophoresis of vinca alkaloids.
    Szücs A; Csillik B; Knyihár-Csillik E
    Recent Results Cancer Res; 1984; 89():185-9. PubMed ID: 6695098
    [No Abstract]   [Full Text] [Related]  

  • 12. [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
    González Larriba JL; Alberola V; Lianes P; Panizo A; Carrato A; Muñoz Quintana A; Cardenal F; Gracia JM; Moyano A; Díaz-Rubio E
    Rev Clin Esp; 1994 Nov; 194(11):953-9. PubMed ID: 7846351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vinorelbine for non-small cell lung cancer].
    Seto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract]   [Full Text] [Related]  

  • 14. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
    Bhushana Rao KS; Collard MP; Trouet A
    Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the treatment of non-small cell lung cancer].
    Sculier JP
    Pathol Biol (Paris); 1992 Nov; 39(9):938-9. PubMed ID: 1311447
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost-effectiveness analysis: a reader's guide].
    Vergnenègre A
    Rev Mal Respir; 2003 Feb; 20(1 Pt 1):116-25. PubMed ID: 12709640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
    Coltman CA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antitumor derivatives of vinblastine].
    Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
    Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinca alkaloids.
    Chabner BA; Horwitz SB; Clendennin NJ; Purvis JD
    Cancer Chemother Biol Response Modif; 1991; 12():67-73. PubMed ID: 1681845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.